Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP741344.RAeJEuXHQiyEQXYKJ525VhHG06kyAad3HehJPEZc8IAIc130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741344.RAeJEuXHQiyEQXYKJ525VhHG06kyAad3HehJPEZc8IAIc130_provenance.
• NP369794.RAiPngdMB2_GTju6RVoA99vClRedfZlKNBGOh4DJreF3s130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369794.RAiPngdMB2_GTju6RVoA99vClRedfZlKNBGOh4DJreF3s130_provenance.
• NP432377.RALgIpqsS_ApcGXSH-AkGScrJ5dE_T1-5rQB6GM7qyNL0130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432377.RALgIpqsS_ApcGXSH-AkGScrJ5dE_T1-5rQB6GM7qyNL0130_provenance.
• NP795418.RAsHwBiTxdOvC4fZQv2R91K_J1XcPIR_gK9DU1zvhygDU130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795418.RAsHwBiTxdOvC4fZQv2R91K_J1XcPIR_gK9DU1zvhygDU130_provenance.
• NP291062.RAxpdogjjFsKKMsaNUvSlL-Bwhj4jHEi6oNDRii91Jmfk130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291062.RAxpdogjjFsKKMsaNUvSlL-Bwhj4jHEi6oNDRii91Jmfk130_provenance.
• NP378181.RAT15f0AlTjbmmtEkUh7CgF93qHRu58RTYpmM9RSNCCbk130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378181.RAT15f0AlTjbmmtEkUh7CgF93qHRu58RTYpmM9RSNCCbk130_provenance.
• NP771430.RAaTjCbgSURwQiy_EeLBlWmYjK7zBZFxXClEMJBS1s168130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771430.RAaTjCbgSURwQiy_EeLBlWmYjK7zBZFxXClEMJBS1s168130_provenance.
• NP771953.RAwJV-cGvfjuOLyGoTGIBbfMtRK5rSzSf86as9cA1CzhE130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771953.RAwJV-cGvfjuOLyGoTGIBbfMtRK5rSzSf86as9cA1CzhE130_provenance.
• NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926110.RA-YNPq5em5TaFyPXWSX48RCUOpwdC50HnWiFO0fJt9-I130_provenance.
• NP926112.RAabHiJAtr1W8YYNYpTL7SX7yv7iaIV8pulgIkt3FNBwU130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926112.RAabHiJAtr1W8YYNYpTL7SX7yv7iaIV8pulgIkt3FNBwU130_provenance.
• NP926109.RAr39f9Lulds6fsEdOohQbLZT-poaolNkM0yBuMlO5tSM130_assertion description "[Based on studies showing that plasmid-mediated vascular endothelial growth factor (pVEGF) gene transfer reduces infarct size by combining angio-arteriogenic and cardiomyogenic effects and that erythropoietin (EPO) exerts anti-apoptotic actions in animal models of AMI, we aimed to assess if their association would reduce infarct size to a larger extent than any of them individually in a large mammalian model of RAMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926109.RAr39f9Lulds6fsEdOohQbLZT-poaolNkM0yBuMlO5tSM130_provenance.